Lappaconitine

CAS No. 32854-75-4

Lappaconitine ( Lappaconitine )

Catalog No. M14074 CAS No. 32854-75-4

Lappaconitine, isolated from Aconitum sinomontanum Nakai, was characterized as analgesic principle.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 36 Get Quote
10MG 51 Get Quote
25MG 85 Get Quote
50MG 125 Get Quote
100MG 178 Get Quote
200MG 267 Get Quote
500MG 462 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lappaconitine
  • Note
    Research use only, not for human use.
  • Brief Description
    Lappaconitine, isolated from Aconitum sinomontanum Nakai, was characterized as analgesic principle.
  • Description
    Lappaconitine, isolated from Aconitum sinomontanum Nakai, was characterized as analgesic principle.
  • Synonyms
    Lappaconitine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    32854-75-4
  • Formula Weight
    584.64
  • Molecular Formula
    C32H44N2O8
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CCN1C[C@@]2(CC[C@H](OC)[C@@]34[C@@H]2C[C@@H]([C@@H]13)[C@@]5(O)C[C@H](OC)[C@H]6C[C@@H]4[C@]5(O)[C@H]6OC)OC(=O)c7ccccc7NC(=O)C
  • Chemical Name
    (3S,6S,6aS,7S,7aS,8S,9R,10S,11aS,12S,12aR,14S)-1-ethyl-7a,11a-dihydroxy-6,8,10-trimethoxydodecahydro-2H-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocin-3(4H)-yl 2-acetamidobenzoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bryzgalov AO, et al. Cardiovasc Hematol Agents Med Chem. 2013 Sep;11(3):211-7.
molnova catalog
related products
  • Ursolic acid

    Ursolic acid(Bungeolic acid) is a natural pentacyclic triterpenoid carboxylic acid, exerts anti-tumor effects and is an effective compound for Y prevention and therapy.

  • SDZ285-428

    NVP-VID-400 (SDZ285-428) is a CYP24A1 inhibitor.

  • B2

    B2 promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease.